Hematology NewsIsatuximab added to RVd boosts response in new myelomaDecember 13, 2021Multiple Myeloma
Hematology NewsFDA approves time-saving combo for r/r multiple myelomaDecember 2, 2021Multiple Myeloma
Oncology PracticeSevere COVID two times higher for cancer patientsNovember 8, 2021Breast CancerCOVID-19 UpdatesHead & Neck/Thyroid CancersGynecologic CancerGI OncologyGenitourinary CancerGastrointestinal Cancer
Hematology NewsFDA warns of higher death risk with Pepaxto in multiple myelomaJuly 28, 2021Multiple MyelomaLymphoma & Plasma Cell Disorders
Oncology PracticePersonalized cancer vaccine shows early promise across tumor typesApril 14, 2021Patient & Survivor CareMultiple MyelomaBreast CancerGenitourinary CancerLymphoma & Plasma Cell DisordersHead & Neck/Thyroid CancersLung Cancer
Oncology PracticeCancer screening stopped by pandemic: Repercussions to come?April 8, 2021Patient & Survivor CareLung CancerBreast CancerGastrointestinal CancerGynecologic CancerCOVID-19 UpdatesMixed Topics
Hematology NewsSteroids can be stopped in some older multiple myeloma patientsApril 1, 2021Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsFirst CAR T-cell therapy for multiple myeloma: AbecmaMarch 29, 2021Multiple MyelomaLymphoma & Plasma Cell Disorders
Oncology PracticeFDA scrutinizes cancer therapies granted accelerated approvalMarch 18, 2021Patient & Survivor CareBreast CancerGastrointestinal CancerGenitourinary CancerLung CancerLymphoma & Plasma Cell DisordersMultiple Myeloma
Oncology PracticeDon’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021Patient & Survivor CareAggressive LymphomasB Cell LymphomaT Cell LymphomasMultiple MyelomaMantle Cell LymphomaIndolent Lymphoma
Hematology News‘Phenomenal’ results with CAR T cells in R/R multiple myelomaMarch 4, 2021Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsSteroid complications in GVHD common, boost costs of careFebruary 19, 2021TransplantALLMultiple MyelomaDLBCLB Cell LymphomaLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Hematology NewsChronic GVHD therapies offer hope for treating refractory diseaseFebruary 17, 2021TransplantLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMyelodysplastic SyndromeMultiple MyelomaALLAML
Hematology NewsCaregiver burden of outpatient ASCT for multiple myeloma comparable with inpatient transplantDecember 18, 2020Multiple MyelomaTransplantLymphoma & Plasma Cell Disorders
Hematology NewsStudy found dual-targeted CAR T highly active against relapsed/refractory multiple myelomaDecember 15, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
